The hemp industry woke up on April 22, 2026 caught between two federal forces pulling in opposite directions: a surging market and a landmark Medicare win on one side, and a compliance cliff just six months away on the other. Here is what happened today, why it matters, and what operators should watch next.

 

The Compliance Cliff Is Now Six Months Away

The November 12, 2026 effective date of the redefined federal hemp rules is no longer a distant worry — it is a quarterly planning problem. The new law replaces the delta-9-only standard with a total-THC framework, imposes a 0.4 milligram total-THC cap per finished container, and excludes synthetic and chemically converted cannabinoids from the legal definition of hemp. The US Hemp Roundtable estimates the rule will wipe out roughly 95% of products currently on shelves.

Charlotte, N.C. is one of the most visible canaries in this coal mine. Local brewers and bottle shops that built fast-growing THC-beverage lines are warning that a federal ban on hemp-derived drinks — a category that topped $1.1 billion in national sales last year — could erase a business many of them pivoted to when craft beer softened. Similar pressure is showing up in Minnesota, where the state's roughly $180 million hemp-THC drink and edible market is staring down the same November deadline.

Medicare Starts Paying for CBD

On a far more optimistic note, Medicare — the federal health insurance program covering roughly 68 million Americans — began covering hemp-derived CBD products for eligible seniors this month. A new FDA enforcement memo cleared the runway for the pilot, and Cornbread Hemp secured an exclusive supply contract through Alliant Purchasing, a GPO that serves 68,000 healthcare locations. It is the first time in U.S. history that a federal payer has reimbursed hemp CBD, and it hands the industry a new legitimacy argument at exactly the moment it needs one.

Analysts have flagged the obvious tension: Washington is simultaneously paying for CBD and preparing to ban most hemp products. Expect the Medicare pilot to become a centerpiece of lobbying arguments for a CBD carve-out in any technical fix to the 2026 rules.

Bipartisan Push to Delay the Ban

Senators Rand Paul (R-KY) and Amy Klobuchar (D-MN), joined by Senator Jeff Merkley (D-OR), have introduced legislation to create a regulated pathway for hemp products in states with existing programs, mirroring Representative Baird's Hemp Planting Predictability Act (H.R. 7024) in the House. That bill would replace the current 365-day implementation window with a three-year runway — pushing the effective date to November 12, 2028. Representative Morgan Griffith has separately introduced a bill to establish a first-of-its-kind federal regulatory framework for hemp-derived products, signaling that at least part of Congress wants to regulate rather than prohibit.

State-Level Action: Missouri, Texas, and Beyond

•       Missouri: Governor Mike Kehoe's office received 10,000 handwritten letters this week urging a veto of the state's intoxicating-hemp ban, which would clear shelves on November 12.

•       Texas: A Travis County district judge has temporarily blocked the statewide ban on smokeable hemp products, including flower and pre-rolls, at least through April 23 — keeping retailers open for now while the court weighs an extension.

•       Pennsylvania, Rhode Island, Ohio: All three are advancing proposals to tighten hemp rules in ways that mirror the incoming federal framework — a sign that state legislatures are not waiting for Washington to finish the job.

The Macro Number: $739 Million

Against all this regulatory turbulence, a new federal report pegged the U.S. hemp industry at $739 million in total production value for 2025, a 64% jump over 2024. Outdoor floral hemp alone reached 33.2 million pounds (up 60%) and $574 million in value — about 90% of the outdoor total. Farmers planted 49,267 acres, a 9% increase year over year. In other words, the ban is arriving in a market that just had its best year since the 2018 Farm Bill.

What to Watch This Week

•       The Texas smokeable-hemp ruling, expected by April 23.

•       Missouri's veto decision on the intoxicating-hemp ban.

•       Any Senate Agriculture activity around the Paul-Klobuchar-Merkley package and H.R. 7024.

•       Early performance data from the Medicare CBD pilot — utilization numbers will shape the carve-out debate.

The Bottom Line

Today's headlines capture a single, sharper truth: hemp's legal story is being rewritten in real time, and 2026 is the year the industry either secures a workable federal framework or absorbs the largest product contraction in its modern history. Operators who plan for the November deadline while participating in the Medicare-era legitimacy story will be best positioned either way.